Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 13Oropharyngeal Neoplasms 12Lung Neoplasms 9Laryngeal Neoplasms 8Carcinoma 8Mouth Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Hypopharyngeal Neoplasms 6Uterine Cervical Neoplasms 5Nasopharyngeal Carcinoma 5Mesothelioma, Malignant 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Triple Negative Breast Neoplasms 3Salivary Gland Neoplasms 3Ovarian Neoplasms 3Lymphoid Interstitial Pneumonia 3Gallbladder Neoplasms 3Testicular Neoplasms 2Seminoma 2Paranasal Sinus Neoplasms 2Medulloblastoma 2Ganglioneuroblastoma 2Fallopian Tube Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Breast Neoplasms 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1durvalumab 1Vinblastine 1Specimen Handling 1Platinum 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Pelvis and Ureter Urothelial Carcinoma × Platinum × 90 days × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡